FR3096M - New drug in particular for the treatment of states of adynamia. - Google Patents

New drug in particular for the treatment of states of adynamia.

Info

Publication number
FR3096M
FR3096M FR950073A FR950073A FR3096M FR 3096 M FR3096 M FR 3096M FR 950073 A FR950073 A FR 950073A FR 950073 A FR950073 A FR 950073A FR 3096 M FR3096 M FR 3096M
Authority
FR
France
Prior art keywords
adynamia
states
treatment
new drug
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR950073A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR940884A external-priority patent/FR1453215A/en
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR950073A priority Critical patent/FR3096M/en
Application granted granted Critical
Publication of FR3096M publication Critical patent/FR3096M/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C07H11/04Phosphates; Phosphites; Polyphosphates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
FR950073A 1963-07-09 1963-10-09 New drug in particular for the treatment of states of adynamia. Expired FR3096M (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR950073A FR3096M (en) 1963-07-09 1963-10-09 New drug in particular for the treatment of states of adynamia.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR940884A FR1453215A (en) 1963-07-09 1963-07-09 Novel salt of glucose-1-phosphoric acid and method of preparation
FR950073A FR3096M (en) 1963-07-09 1963-10-09 New drug in particular for the treatment of states of adynamia.

Publications (1)

Publication Number Publication Date
FR3096M true FR3096M (en) 1965-02-01

Family

ID=8814032

Family Applications (1)

Application Number Title Priority Date Filing Date
FR950073A Expired FR3096M (en) 1963-07-09 1963-10-09 New drug in particular for the treatment of states of adynamia.

Country Status (1)

Country Link
FR (1) FR3096M (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4983582A (en) * 1987-02-13 1991-01-08 Kao Corporation Preventive and therapeutic method for hypertension

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4983582A (en) * 1987-02-13 1991-01-08 Kao Corporation Preventive and therapeutic method for hypertension

Similar Documents

Publication Publication Date Title
FR3069M (en) New drug, in particular for the treatment of protein anabolic disorders.
FR3851M (en) New drug in particular for the treatment of hypercholesterolemia and the resulting disorders.
FR2963M (en) New drug, in particular for the treatment of protein anabolic disorders.
FR3845M (en) New drug in particular for the treatment of hypercholesterolemia and the resulting disorders.
FR1438M (en) New drug effective in the treatment of atherosclerosis.
FR3395M (en) New drug, in particular for the treatment of neurodepressive states and anxiety psychoses.
FR3096M (en) New drug in particular for the treatment of states of adynamia.
FR3066M (en) New drug, in particular for the treatment of postprandial or chronic hyperlipemia.
FR2969M (en) New drug in particular for the treatment of spasms of coronary or visceral origin.
FR3187M (en) New drug in particular for the treatment of irregularities and ovarian insufficiencies.
FR3641M (en) New drug in particular for the treatment of states of adynamia.
FR3126M (en) New drug, in particular for the treatment of neuro-depressive states and anxiety psychoses.
FR2885M (en) New drug, in particular for the treatment of neuro-depressive states and anxiety psychoses.
FR3062M (en) New drug, in particular for the treatment of neurodepressive states and anxiety psychoses.
FR3315M (en) New drug, in particular for the treatment of neurodepressive states and anxiety psychoses.
FR3268M (en) New drug, in particular for the treatment of neurodepressive states and anxiety psychoses.
FR2413M (en) New drug, in particular for the treatment of inflammatory and painful manifestations.
FR3532M (en) New drug, in particular for the treatment of hypercholesterolemia and the resulting disorders.
FR2810M (en) New drug in particular for the treatment of spasms of coronary or visceral origin.
FR151M (en) New drug, in particular for the treatment of neuro-depressive states and anxiety psychoses.
FR3392M (en) Dermatological medicinal product, in particular for the treatment of oozing eczema.
FR2805M (en) New drug in particular for the treatment of affections of bacterial origin.
FR3031M (en) New drug in particular for the treatment of hypercholesterolemia and the resulting disorders.
FR2458M (en) New drug in particular for the treatment of depressive states or anxiety.
FR1122M (en) New drug in particular for the treatment of hypercholesterolemia.